Japan: Danaher Group Solutions & Case Studies Supporting Biomarker Discovery and Evaluation in Drug Discovery

*This webinar will be presented in Japanese.

Genedata will present the following talk at a webinar co-hosted with Leica Mirosystems, Abcam, and Molecular Devices.

From Discovery to Clinical Utility: Thinking Plasma Biomarkers for Alzheimer’s Disease End-to-End
Shunya Kondo, Ph.D., Scientific Business Consultant, Genedata AG

Translating biomarker discoveries into clinically reliable and scalable blood-based diagnostics for Alzheimer’s disease remains challenging. In this webinar, we present an end‑to‑end Alzheimer’s biomarker program facilitating this process. We demonstrate how proteomic profiling can complement established markers, and how an integrated, governed data and analytics approach enables multi‑modal analysis, cross‑disciplinary collaboration, and smoother transitions from discovery to diagnostic translation.